Short Communication
Open Access

Stimulation of Osteogenesis to Fight Osteoporosis

Maciej Pawlikowski

AGH University of Science and Technology, Department of Mineralogy, Petrography and Geochemistry, Lab. Biomineralogy, 30-059 Krakow, al. Mickiewicza 30, Poland

*Corresponding Author: Maciej Pawlikowski, AGH University of Science and Technology, Department of Mineralogy, Petrography and Geochemistry, Lab. Biomineralogy, 30-059 Krakow, al. Mickiewicza 30, Poland, E-mail: mpawlik@agh.edu.pl

Received: 05 March 2018; Accepted: 18 April 2018; Published: 20 April 2018


Keywords:

Osteogenesis; Osteoporosis

Untitled Document

Osteoporosis is not just a phenomenon of bone demineralization and related problems, such as increased bone fragility or problems with bone knitting. Osteoporosis is also a problem of reduction of the internal surface of spongy bone. It was calculated that the total bone surface area - the surface of ??all trabeculae in all bones - can be anywhere between 380,000 and 420,000 m2 in an adult [1-5]. On such surface area, bone marrow and other bone components come into contact with trabeculae, including microcrystals of carbonate hydroxyapatite - a mineral bone component.

On this surface area, the chemico-physical balance is maintained between the marrow, blood vessels and others bone components, and phosphate and trabeculae collagen. Obviously, that balance changes with the loss of trabeculae and minerals in the osteoporosis process. The changes are the greater the more developed osteoporosis.

Another important problem is the transfer of elements from bones to soft tissues [18]. In the process of osteoporosis, not all elements released from bones are excreted outside the body. Some of them flow with blood and other body fluids and may settle in various places in tissues and organs. This leads first to so-called hidden mineralization, and later, as a result of further crystallization, to overt mineralization (calcifications). Hidden mineralization can be observed only in the results of chemical analyzes; it consists of substituting elements (mainly Ca and P) in biological structures in so-called crystallization centers [22-24].

The harmfulness of such mineralization (of arteries, heart valves, joint cartilage, etc.), not to mention its potential carcinogenic effect, does not require detailed discussion [6-21].

Therefore, stopping the progress of osteoporosis, its prevention, and, above all, elimination of osteoporosis entirely, is one of the most important medical problems, or even one of the biggest challenges for humanity.

Different methods of fighting osteoporosis are widely known, including using high calcium medication and others substances. However, reconstruction of spongy bone trabeculae affected by osteoporosis cannot be done by administering calcium and phosphorus. These elements, delivered to a usually older organism (e.g. in the form of tablets), do not necessarily go to the bone. If they encounter crystallization centers in other places than bones - arteries, cartilage, etc. - they eagerly join biological structures there [24], promoting the formation of mineralization (calcifications). Considering the fact that osteoporosis, and especially elements derived from bones in osteoporosis, can mineralize tissues [18], additional doses of calcium and phosphorus introduced for the “treatment" of osteoporosis accelerate the formation of calcifications outside the bones, which can lead to many "accelerated" health problems.

For the reconstruction of trabeculae we need collagen, with programmed crystallization centers where hydroxyapatite will crystallize again. It crystallizes in the bones from alkaline phosphatase produced by osteoblast mitochondria. This means that we should also "mobilize" osteoblasts to re-synthesize alkaline phosphatase.

When collagen is synthesized with crystallization centers (in the appropriate places of its structure) and alkaline phosphatase is present, the trabeculae will be reconstructed. The result will be strengthening of the spongy bone structure at sites affected by osteoporosis.

How can we start this mechanism? In certain circumstances, it starts on its own. This happens in bone fractures, when the "osteosynthesis" process that occurs in the body from the moment of bone formation to their full mineralization is "repeated" in a natural way.

So what is the factor that creates osteogenesis in bone knitting? Can this mechanism be used to strengthen bones affected by osteoporosis?

Conducted research and observations of the bone knitting process suggest that indeed [6], this mechanism can be activated. Fine-tuning the method and entering the phase of its application requires a series of further experiments and additional time-consuming, costly tests.

Conducted research and observations of the bone knitting process suggest that yes, this mechanism can be started [6]. Fine-tuning the method and reaching the phase of its application requires a series of further experiments and additional time-consuming, costly tests.

References

  1. Nied?wiedzki T, Pawlikowski M. Zmiany mineralogiczne zachodz?ce w obszarze gojenia z?ama? ko?ci d?ugich. (Mineralogical phenomena observed at healing part of broken bones). Chirurgia Narz. Ruchu i Ortop. Pol. T. LV (1990): 277-281.
  2. Nied?wiedzki T, D?browski Z, Miszta H, Pawlikowski M. Bone healing after bone marrow stromal cell transplantation to the bone defect. Biomaterials 14 (1993): 115-121.
  3. Pawlikowski M.  Mineralizacja organizmu cz?owieka ?yj?cego. (Mineralization of human living organism). Prace Mineral (1987) 79: 121.  
  4. Pawlikowski M, Ryskala Z, Charakterystyka mineralogiczno-chemiczna fosforanowej mineralizacji wybranych naczy? t?tniczych cz?owieka. (Mineralogical - chemical characteristic of phosphate mineralization of human arteries). Roczniki Nauk.- Dyd. WSP w Krakowie Prace Fizjologiczne 1991: 81-104.
  5. Pawlikowski M. Mineralizacja nowotworowa (Mineralization of cancer). W:  Biomineralizacja i biomateria?y. PWN,  Warszawa 1991: 84-92.
  6. Pawlikowski M. Kryszta?y w organizmie cz?owieka. (Crystals of  human organism). Secesja. (Atlas) 1993:132.     
  7. Pawlikowski M. Sekrety mineralizacji tkanek (Secrets of tissue mineralization).  PAN, Kraków 1995 :97.     
  8. Pawlikowski M. Preliminary results of dissolution of substances mineralizing human arteries. Arch Mineralog  (1999) 52: 195-210.
  9. Pawlikowski M. Pfitzner R. Zastosowanie metod mineralogicznych w badaniach tkanek cz?owieka. I. Sposoby badania mineralizacji. (Mineralogical methods useful for examination of human tissues). Przegl. Lekarski  52 (1995): 119-123.
  10. Pawlikowski M. Pfitzner R Zastosowanie metod mineralogicznych w badaniach tkanek cz?owieka. II. Mineralizacja struktur serca. (Mineralogical methods useful for examination of human tissues. Mineralization of heart structures). Przegl Lekarski 52 (1995): 24-27.
  11. Pawlikowski M. Pfitzner K, Skinner C. Cholesterol-mineral concentrations of the aneurysmatic wall. Acta Angiologica (1995d) Supl. 1: 15.      
  12. Pawlikowski M. Pfitzner R. Mineralizacja serca i du?ych naczy?. (Mineralization of heart and big blood vessels). Wyd. IGSMiE PAN Kraków (1999): 142 p.   
  13. Pawlikowski M. Nied?wiedzki T, Mineralogia ko?ci. (Mineralogy of bones). Wyd. PAN Oddzia? w Krakowie 2002: 128
  14. Pawlikowski M.  Minerals in human blood vessels and their dissolution in vitro. In: Skinner HCW, Berger AW, Geology and health. N.Y. ? Oxford. Oxford University Press  2003: 155-158.      
  15. Pawlikowski M. Biomineralization of cancer tissues. 20th Int. Symp. Molecular and Physiological Aspects of Regulatory Processes of the Organism. Cracow. Ed. H. Lach. Wyd. Abaton. Kraków 2011:190-191.
  16. Pawlikowski M,  Kwinta A,  Zwolinska B,  Kwinta K,  Green fiber lasers in urology. Folia Med.  Cracov 53 (2013): 23-34.
  17. Pawlikowski M. Mineralizacja guzów nowotworowych p?uc. (Mineralization of lung cancer tumors. Auxiliary sciences in archaeology, preservation of relicts and emvironmental engineering (2013a)  CD -no 15, Ed. M. Pawlikowski.
  18. Pawlikowski M. Osteoporosis as a source of tissue mineralization. Research on osteoporosis therapy and dissolution of arterial mineralization. Jour Life Science 8 (2014): 610-625.
  19. Pawlikowski M. Biomineralogy of osteoporosis. Academia Journal of Biotechnology 4 (2016): 138-144
  20. Pawlikowski M. Biomineralogical investigation of apatite piezoelectricity.  Traumatologia i ortopedia Rosiji 2 (2016): 58-63.
  21. Pawlikowski M. Electric phenomenon in bones as a result of piezoelectricity of hydroxyapatite. Arch. Clin. Biomed. Res 1 (2016): 132-139
  22. Pawlikowski M. Biomineralogy of angiogenesis. Arch Clin Biomed Res 1 (2017): 161-167
  23. Pawlikowski M. Miler  M, Biomineralogy of selected skin cancer. SM Dermatolog J 3 (2017): 1017
  24. Pawlikowski M. Centers of Human Tissue Biomineralization (Calcification). Cardiol. Cardiovasc Med 1 (2017): 252-261.

Citation: Maciej Pawlikowski. Stimulation of Osteogenesis to Fight Osteoporosis. Archives of Clinical and Biomedical Research 2 (2018): 104-107.